# Pfizer Inc. (NYSE: PFE), Parsippany, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/pfizer-inc/95f0f34c-638b-4a6b-8c65-35fb37711e6b

> Inspection records and compliance data for Pfizer Inc. in Parsippany, New Jersey. 6 FDA inspections on record, 1 Form 483, last inspected September 29, 2026. Publicly traded as NYSE: PFE.

---

## Details

- Name: Pfizer Inc.
- FEI Number: 3003836868
- Business Operations: API/FDF ANALYTICAL TESTING
- Address Line 1: 400 Webro Rd
- City: Parsippany
- State: New Jersey
- Zip Code: 07054
- Country Name: United States
- Address: 400 Webro Rd, Parsippany, New Jersey 07054, United States
- Country: United States

## Stock

- Stock ticker: PFE
- Exchange: NYSE
- Share price: $28.84
- Market cap: $164.4B
- Price as of: November 13, 2026

## Related Documents

- [FDA Inspection 1338628 - Pfizer Inc. - 2026-09-29](https://www.keypedia.com/records/fda_inspections/pfizer-inc/4057bc9d-ffe0-4d70-ab21-41af1cfacb04) — source: FDA, date: September 29, 2026
- FDA Inspection 1256978 - Pfizer Inc. - 2025-06-18 — source: FDA, date: June 18, 2025
- FDA Inspection 1256978 - Pfizer Inc. - 2025-06-18 — classification: No Action Indicated (NAI), source: FDA, date: June 18, 2025
- [EIR - Pfizer Inc. - 2022-09-28](https://www.keypedia.com/records/eir/pfizer-inc/e5c7bb44-06ce-4ca8-b264-c3d433519b9b) — source: FDA, date: September 28, 2022
- FDA Inspection 1181324 - Pfizer Inc. - 2022-09-28 — classification: No Action Indicated (NAI), source: FDA, date: September 28, 2022
- FDA Inspection 971684 - Pfizer Inc. - 2016-06-02 — classification: No Action Indicated (NAI), source: FDA, date: June 2, 2016
- FDA Inspection 847159 - Pfizer Inc. - 2013-09-05 — classification: No Action Indicated (NAI), source: FDA, date: September 5, 2013
- FDA Inspection 714537 - Pfizer Inc. - 2011-03-11 — classification: No Action Indicated (NAI), source: FDA, date: March 11, 2011

## Related Companies

- [Appco Pharma, LLC](https://www.keypedia.com/companies/appco-pharma-llc/63262db1-9074-411f-915f-f0b3e49884b8)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/f88df458-d615-433c-956b-d484506e4986)
- [BioTel Research, LLC](https://www.keypedia.com/companies/biotel-research-llc/2a9f13e0-a9ee-4e1b-a154-2190996d80db)
- [Gilead Sciences Inc](https://www.keypedia.com/companies/gilead-sciences-inc/25d591ee-1217-4ca3-9134-ed69477f677f)
- [Hercon Pharmaceuticals, LLC](https://www.keypedia.com/companies/hercon-pharmaceuticals-llc/fec71b58-f9ca-4d72-a14a-c02da0a17760)
- [PAI Holdings, LLC, dba Pharmaceutical Associates, Inc](https://www.keypedia.com/companies/pai-holdings-llc-dba-pharmaceutical-associates-inc/8c0bd848-8106-4ffb-9eac-4202f50a39ab)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/3132b954-14e5-4ee9-bf30-7ae06ff6899e)
- [David L. Wirta, M.D.](https://www.keypedia.com/companies/david-l-wirta-md/f239b2b9-d44b-4aa0-b2e3-3506e3831bae)
- [AltaSciences Clinical Los Angeles Inc.](https://www.keypedia.com/companies/altasciences-clinical-los-angeles-inc/977107a9-0682-40d1-b775-8c0cb8c7e822)
- [Nesher Pharmaceuticals (USA) LLC](https://www.keypedia.com/companies/nesher-pharmaceuticals-usa-llc/d0fd36a5-057e-46eb-8fb3-828cd2c27388)

## Related Officers

- [Robin P. Mathew](https://www.keypedia.com/people/robin-p-mathew/35f4a085-58b8-4208-a648-ef2d533e1ece)
- [investigator](https://www.keypedia.com/people/monika-borkowska/4dedee7d-7b93-4f1b-be3b-17ab41e5c0ff)
